Skip to main content
. Author manuscript; available in PMC: 2023 Jun 6.
Published in final edited form as: Circ Heart Fail. 2020 Sep 9;13(9):e007099. doi: 10.1161/CIRCHEARTFAILURE.120.007099

Table 3.

Baseline characteristics of CSWG study population by congestion profile

Congestion Profile

Euvolemic Left Ventricular Right Ventricular Biventricular

N (%) N (%) N (%) N (%) p-value
Mortality 24 (16.9) 35 (18.8) 23 (34.9) 143 (36.9) <0.001
Shock Etiology 0.01
MI 39 (27.5) 45 (24.2) 29 (43.9) 111 (28.6)
HF 88 (62.0) 120 (64.5) 25 (37.9) 238 (61.5)
Other 15 (10.6) 21 (11.3) 12 (18.2) 38 (9.8)
SCAI Stage 0.06
B 1 (2.4) 0 (0) 0 (0) 0 (0)
C 14 (33.3) 29 (43.9) 9 (22.0) 75 (35.9)
D 17 (40.5) 23 (34.9) 14 (34.2) 71 (34.0)
E 10 (23.8) 14 (21.2) 18 (43.9) 63 (30.1)
# Pressors/Inotropes <0.001
0 40 (29.0) 25 (13.6) 7 (10.8) 60 (15.9)
1 49 (35.5) 75 (40.8) 19 (29.2) 116 (30.7)
2+ 49 (35.5) 84 (45.7) 39 (60.0) 202 (53.4)
# Devices <0.001
0 64 (45.1) 50 (26.9) 10 (15.2) 60 (15.5)
1 56 (39.4) 104 (55.9) 30 (45.5) 233 (60.1)
2+ 22 (15.5) 32 (17.2) 26 (39.4) 95 (24.5)
Device Type
Impella 29 (20.4) 48 (25.8) 24 (36.4) 116 (30.0) 0.06
ECMO 19 (13.4) 25 (13.4) 22 (33.3) 89 (22.9) <0.001
IABP 52 (36.6) 96 (51.6) 36 (54.6) 223 (57.5) <0.001
Male 99 (69.7) 141 (75.8) 45 (68.2) 267 (68.8) 0.35
Race 0.10
White 79 (71.8) 105 (80.8) 38 (84.4) 183 (77.2)
Hispanic/Latino 1 (0.9) 1 (0.8) 2 (4.4) 10 (4.2)
African-American 4 (3.6) 3 (2.3) 1 (2.2) 8 (3.4)
Asian 3 (2.7) 1 (0.8) 2 (4.4) 9 (3.8)
Other 23 (20.9) 20 (15.4) 2 (4.4) 27 (11.4)
Medical History
HTN 59 (43.1) 76 (43.7) 32 (50.8) 180 (51.9) 0.35
DM2 41 (29.1) 57 (30.7) 22 (33.9) 141 (36.4) 0.33
Afib/Flutter 33 (27.1) 51 (33.3) 18 (33.3) 123 (40.2) 0.07
CKD (any stage) 36 (26.9) 45 (26.6) 11 (18.3) 104 (30.6) 0.24
PVD 6 (4.6) 6 (3.7) 5 (8.6) 20 (6.4) 0.44
COPD 12 (8.8) 12 (6.9) 3 (4.8) 40 (11.1) 0.23
CVA/TIA 22 (16.1) 28 (16.2) 6 (9.5) 52 (14.4) 0.60
Valvular Disease 25 (21.2) 39 (26.5) 16 (29.6) 75 (26.3) 0.61
PCI 25 (20.8) 43 (29.5) 23 (42.6) 71 (25.7) 0.02
CABG 9 (6.8) 13 (8.2) 8 (13.8) 32 (10.4) 0.39
VT 36 (29.5) 41 (26.6) 15 (27.8) 71 (23.1) 0.54
ICD 54 (44.3) 77 (50.0) 11 (20.0) 116 (37.9) <0.001
CRT 16 (13.1) 18 (11.7) 1 (1.8) 36 (11.8) 0.14
Mean SD Mean SD Mean SD Mean SD

Demographic
Age 56.5 15.4 57.6 15.4 60.6 14.9 59.4 14.7 0.11
Weight (kg) 81.6 20.1 82.5 20.3 83.2 22.8 87.1 22.1 0.03
Metabolic
AST 452.3 1552.6 340.2 1067.9 860.9 3070.4 447.0 1447.0 0.29
BUN 28.3 15.7 31.2 19.2 32.2 22.1 37.6 22.8 <0.001
Lactate 3.6 3.3 3.7 4.5 5.1 3.4 4.7 3.4 0.13
HCO3 23.7 4.9 23.9 5.2 20.0 5.5 22.2 5.7 <0.001
Serum Creatinine 1.6 0.8 1.5 1.0 1.8 1.5 1.9 1.2 0.002
pH 7.3 0.1 7.4 0.1 7.3 0.1 7.3 0.1 <0.001
Hemodynamic
EF (%) 22.6 12.2 24.0 16.8 25.2 16.8 23.5 15.2 0.85
RAP 6.7 3.1 8.7 2.9 16.7 3.5 19.2 5.1 <0.001
PCWP 13.2 3.9 25.6 5.3 15.8 2.4 29.3 7.4 <0.001
Mean PAP 23.3 6.8 33.6 6.9 25.8 8.3 37.3 9.0 <0.001
Cardiac Output 4.0 1.6 3.6 0.9 4.2 2.9 3.9 3.3 0.40
CPO 0.6 0.3 0.6 0.2 0.7 0.5 0.6 0.5 0.57
Heart rate 83.8 19.0 90.2 19.2 91.6 23.9 93.8 21.4 <0.001
Cardiac Index 2.0 0.5 1.9 0.5 1.9 0.6 1.8 0.6 <0.001
Mean arterial pressure 73.2 13.6 74.7 13.6 71.9 19.1 73.7 13.1 0.53

p-values calculated using chi-sq test of independence or ANOVA as appropriate. Abbreviations: Afib: Atrial fibrillation; AST: aspartate aminotransferase; BUN: blood urea nitrogen; CABG: coronary artery bypass grafting; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; CPO: cardiac power output; CRT: cathode-ray tube; CVA: cerebrovascular accident; HCO3: Bicarbonate; HF: heart failure; HTN: Hypertension; ICD: implantable cardioverter defibrillator; MI: myocardial infarction; MAP: mean arterial pressure; PAP: pulmonary arterial pressure; PCI: percutaneous coronary intervention; PCWP: pulmonary capillary wedge pressure; PVD: peripheral vascular disease; RAP: right arterial pressure; TIA: transient ischemic attack; VT: ventricular tachycardia